ACADIA Pharma Momentum Builds Ahead of FDA Meeting

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is higher ahead of this month's key FDA committee meeting

Mar 2, 2016 at 1:09 PM
facebook X logo linkedin

It looks like bullish options traders are getting behind biotech ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) ahead of a key Food and Drug Administration (FDA) meeting later this month. Specifically, the Psychopharmacologic Drugs Advisory Committee will meet on Tuesday, March 29, to discuss ACAD's application for its Parkinson's-related psychosis treatment. Shares of ACAD have added over 16% in the past two days, and were last seen at $19.97. 

This excitement has spilled over into the options pits, where call volume is running at twice the average intraday clip. Furthermore, ACAD's 30-day at-the-money (ATM) implied volatility has to surged to 128.5%, putting it in the 100th percentile of its annual range. Suffice it to say, there's intense demand for ACAD's short-term options. 

Looking back -- and amid relatively low volume -- call buying has been popular on the drugmaker. At the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), ACAD sports a 10-day call/put volume ratio of 11.76, which ranks above 85% of readings from the past year. To put it differently, almost 12 long calls have been initiated for every long put during the past two weeks. 

However, this call-buying trend is complicated by ACAD's elevated short interest levels. For instance, short interest represents almost 20% of the biotech stock's float. At average daily volumes, it'd take bears over six sessions to buy back their bets. With this being the case, ACAD shorts may be hedging their positions with call options

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) has actually struggled on a long-term technical basis. The shares have dropped over 64% since they hit an all-time high of $55.99 in July, and touched an annual low of $16.64 on Feb. 9.

Sign up now for Schaeffer's Market Recap to get all the day's big stock movers, must-know technical  levels, and top economic stories straight to your inbox.


Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI